From the surface of M2 tumor-associated macrophages (TAMs), HLA-E antigen binds to the receptor CD94/NKG2A, which inhibits the expression of NK cell subpopulations and activated cytotoxic T lymphocytes, protecting cells from being destroyed (Marchesi et al., 2013). Here, KLRC1 is linked to neoplasm.